Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

ICN granted orphan drug status for Tiazole

Jan. 18, 2001

Oxigene reports update on vascular targeting program

Jan. 18, 2001

Anticancer compounds from Boehringer Ingelheim acting on kinases

Jan. 17, 2001

Exclusive rights to NX-211 obtained by Gilead from GSK

Jan. 17, 2001

IntraBiotics completes patient enrollment in phase III Protegrin IB-367 Rinse study

Jan. 17, 2001

Update on Active Biotech's TTS products under clinical development

Jan. 17, 2001

Telik and the University of Arizona enter TRAP alliance

Jan. 17, 2001

Genome-derived candidate for oncology identified as part of Millennium/Bayer alliance

Jan. 17, 2001

Xcytrin clinical development program update

Jan. 16, 2001

New antitumor prodrugs activated by FAPalpha

Jan. 15, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Capital remains selective in ‘barbell’ biotech market
BioWorld Asia
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...